1. Home
  2. EXEL vs PNFP Comparison

EXEL vs PNFP Comparison

Compare EXEL & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • PNFP
  • Stock Information
  • Founded
  • EXEL 1994
  • PNFP 2000
  • Country
  • EXEL United States
  • PNFP United States
  • Employees
  • EXEL N/A
  • PNFP N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PNFP Major Banks
  • Sector
  • EXEL Health Care
  • PNFP Finance
  • Exchange
  • EXEL Nasdaq
  • PNFP Nasdaq
  • Market Cap
  • EXEL 9.4B
  • PNFP 9.4B
  • IPO Year
  • EXEL 2000
  • PNFP N/A
  • Fundamental
  • Price
  • EXEL $37.42
  • PNFP $110.19
  • Analyst Decision
  • EXEL Buy
  • PNFP Buy
  • Analyst Count
  • EXEL 18
  • PNFP 13
  • Target Price
  • EXEL $37.59
  • PNFP $122.38
  • AVG Volume (30 Days)
  • EXEL 2.8M
  • PNFP 518.9K
  • Earning Date
  • EXEL 04-29-2025
  • PNFP 04-21-2025
  • Dividend Yield
  • EXEL N/A
  • PNFP 0.87%
  • EPS Growth
  • EXEL 170.77
  • PNFP N/A
  • EPS
  • EXEL 1.76
  • PNFP 5.96
  • Revenue
  • EXEL $2,168,701,000.00
  • PNFP $1,616,179,000.00
  • Revenue This Year
  • EXEL $5.45
  • PNFP $28.57
  • Revenue Next Year
  • EXEL $10.32
  • PNFP $12.95
  • P/E Ratio
  • EXEL $21.43
  • PNFP $18.43
  • Revenue Growth
  • EXEL 18.50
  • PNFP 0.90
  • 52 Week Low
  • EXEL $20.14
  • PNFP $73.62
  • 52 Week High
  • EXEL $40.02
  • PNFP $131.91
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 58.85
  • PNFP 52.45
  • Support Level
  • EXEL $36.68
  • PNFP $102.95
  • Resistance Level
  • EXEL $37.99
  • PNFP $108.00
  • Average True Range (ATR)
  • EXEL 1.09
  • PNFP 3.67
  • MACD
  • EXEL -0.11
  • PNFP 1.18
  • Stochastic Oscillator
  • EXEL 49.87
  • PNFP 91.60

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. Pinnacle operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: